Nido Biosciences Secures $109 Million to Advance Precision Medicines for Neurological Diseases
Leveraging advancements in human genetics and disease understanding, Nido Bio aims to develop a sustainable pipeline of novel small molecule medicines that will improve the daily lives of patients suffering from neurological diseases.